Concepedia

Yogesh Mahadu Khetmalis

YM

Statistics

Publications

6

Citations

111

H-Index

6

Active since

2021

Affiliations

Birla Institute of Technology and Science - Hyderabad Campus(Current)

Birla Institute of Technology and Science, Pilani

Technische Universität Darmstadt

Andhra University

Yogesh Mahadu Khetmalis is an author at Birla Institute of Technology and Science - Hyderabad Campus specializing in medicinal chemistry, pharmacology, and drug design.

ORCID

Publications per year

2021–2024

6

Publications

6

Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis

Adinarayana Nandikolla, Singireddi Srinivasarao, Yogesh Mahadu Khetmalis et al. · Toxicology in Vitro · 2021 · 32 citations

, , +14

Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-<i>a</i>]pyridine analogues

Yogesh Mahadu Khetmalis, Surendar Chitti, Anjani Umarani Wunnava et al. · RSC Medicinal Chemistry · 2022 · 24 citations · Full text

, , +12

Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4(3H)-one-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity

Yogesh Mahadu Khetmalis, Ashna Fathima, Markus Schweipert et al. · International Journal of Molecular Sciences · 2023 · 18 citations · Full text

, , +12

Design, synthesis and biological evaluation of benzo-[<i>d</i>]-imidazo-[2,1-<i>b</i>]-thiazole and imidazo-[2,1-<i>b</i>]-thiazole carboxamide triazole derivatives as antimycobacterial agents

Surendar Chitti, Kevin Van Calster, Davie Cappoen et al. · RSC Advances · 2022 · 14 citations · Full text

, , +14

Design, synthesis, and biological evaluation of tetrahydroisoquinoline based hydroxamate derivatives as HDAC 6 inhibitors for cancer therapy

Yogesh Mahadu Khetmalis, Bakhya Shree, Boddupalli Venkata Siva Kumar et al. · Journal of Molecular Structure · 2023 · 13 citations

, , +8

1–5 of 6